EZH2/H3K27Me3 and phosphorylated EZH2 predict chemotherapy response and prognosis in ovarian cancer

BACKGROUND: EZH2 acts as an oncogene through canonical pathway EZH2/H3K27Me3 and uncanonical pathway pAkt1/pS21EZH2 in many solid tumors including ovarian cancer. However, the clinical value of EZH2/H3K27Me3 and pAkt1/pS21EZH2 remain unclear. In the current study, we aim to investigate the correlati...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:PeerJ
Main Authors: Sun, Si, Yang, Qiang, Cai, E, Huang, Bangxing, Ying, Feiquan, Wen, Yiping, Cai, Jing, Yang, Ping
Formato: Artigo
Idioma:Inglês
Publicado: PeerJ Inc. 2020
Assuntos:
Bioinformatics
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7227641/
https://ncbi.nlm.nih.gov/pubmed/32435534
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7717/peerj.9052
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares